“aerie-pharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
FDA Clears Aerie’s Combo Glaucoma Drug, But Will it Sell? 03/13/19 New York
Nanotech Liquidia Hops IPO Wave as Lead Drug Faces Late-Stage Test 06/29/18 Raleigh Durham
Bio Roundup: Tax Cuts, Drug Approval Record, New Flagship Cash & More 12/22/17 National
Two Months Ahead of Schedule, FDA Clears Aerie Glaucoma Drug 12/19/17 New York
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More 05/26/17 National
Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More 03/03/17 National
Inotek’s Glaucoma Drug Flunks in First Phase 3 Test, Shares Crumble 01/03/17 Boston
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More 09/16/16 National
Aerie Shares Rocket As Glaucoma Drug Hits Mark in Phase 3 09/14/16 New York
Allergan Pays $95M for ForSight VISION5, Eye Insert for Glaucoma 08/11/16 San Francisco
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More 09/21/15 Boston
With Revamped Trial, Aerie, Glaucoma Drug Bounce Back 09/16/15 New York
East Coast Biotech Roundup: PrecisionFDA, Avitide, Foresight & More 08/07/15 Boston
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
East Coast Biotech Roundup: Emulate, Pulmatrix, Synergy & More 06/19/15 New York
Aerie Surges As FDA Agrees to New Goals for Glaucoma Trial 06/16/15 New York
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
Aerie Craters As Glaucoma Drug Comes up Short in Phase 3 04/23/15 New York
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Focused on Glaucoma, Aerie Looks Toward Unblinding Critical Data 03/03/15 New York
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
Glaucoma Race Heats Up, But Inotek Cuts Back Its IPO to $40M 02/18/15 Boston
East Coast Biotech Roundup: Intercept, Idera, Inotek, & More 11/07/14 Boston
Inotek, Chasing Aerie in Glaucoma, Sets Sights on IPO 11/05/14 Boston
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More 11/01/13 Boston
Aerie Gets Lukewarm Reception, Cuts IPO Price to $10 Per Share 10/25/13 New York
East Coast Biotech Roundup: Schenkein, PureTech/JDRF, Sage, & More 10/18/13 Boston
Page 1 of 2 next page »